![HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases | SpringerLink HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs13277-011-0204-3/MediaObjects/13277_2011_204_Fig1_HTML.gif)
HE4 a novel tumour marker for ovarian cancer: comparison with CA 125 and ROMA algorithm in patients with gynaecological diseases | SpringerLink
![Human epididymis protein 4 (HE4) is a novel immunohistochemical marker of neuroendocrine differentiation | SpringerLink Human epididymis protein 4 (HE4) is a novel immunohistochemical marker of neuroendocrine differentiation | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs00428-022-03387-4/MediaObjects/428_2022_3387_Fig1_HTML.jpg)
Human epididymis protein 4 (HE4) is a novel immunohistochemical marker of neuroendocrine differentiation | SpringerLink
![Electrochemical immunomagnetic assay as biosensing strategy for determination of ovarian cancer antigen HE4 in human serum - ScienceDirect Electrochemical immunomagnetic assay as biosensing strategy for determination of ovarian cancer antigen HE4 in human serum - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0039914020302824-fx1.jpg)
Electrochemical immunomagnetic assay as biosensing strategy for determination of ovarian cancer antigen HE4 in human serum - ScienceDirect
![Significance of HE4 estimation in comparison with CA125 in diagnosis of ovarian cancer and assessment of treatment response | Diagnostic Pathology | Full Text Significance of HE4 estimation in comparison with CA125 in diagnosis of ovarian cancer and assessment of treatment response | Diagnostic Pathology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1746-1596-8-11/MediaObjects/13000_2012_Article_730_Fig1_HTML.jpg)
Significance of HE4 estimation in comparison with CA125 in diagnosis of ovarian cancer and assessment of treatment response | Diagnostic Pathology | Full Text
![Comparison of Serum Human Epididymis Protein 4 with Cancer Antigen 125 as a Tumor Marker in Patients with Malignant and Nonmalignant Diseases J.M. Escudero, - ppt video online download Comparison of Serum Human Epididymis Protein 4 with Cancer Antigen 125 as a Tumor Marker in Patients with Malignant and Nonmalignant Diseases J.M. Escudero, - ppt video online download](https://slideplayer.com/slide/6626598/23/images/4/Questions+Is+HE4+a+specific+tumor+marker.jpg)
Comparison of Serum Human Epididymis Protein 4 with Cancer Antigen 125 as a Tumor Marker in Patients with Malignant and Nonmalignant Diseases J.M. Escudero, - ppt video online download
![HE4 is a novel tissue marker for therapy response and progestin resistance in medium- and low-risk endometrial hyperplasia | British Journal of Cancer HE4 is a novel tissue marker for therapy response and progestin resistance in medium- and low-risk endometrial hyperplasia | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fbjc.2016.247/MediaObjects/41416_2016_Article_BFbjc2016247_Fig1_HTML.jpg)
HE4 is a novel tissue marker for therapy response and progestin resistance in medium- and low-risk endometrial hyperplasia | British Journal of Cancer
![Human Epididymis Protein 4 (HE4) Reference Limits in Polish Population of Healthy Women, Pregnant Women, and Women with Benign Ovarian Tumors Human Epididymis Protein 4 (HE4) Reference Limits in Polish Population of Healthy Women, Pregnant Women, and Women with Benign Ovarian Tumors](https://static.hindawi.com/articles/dm/volume-2019/3890906/figures/3890906.fig.001.jpg)
Human Epididymis Protein 4 (HE4) Reference Limits in Polish Population of Healthy Women, Pregnant Women, and Women with Benign Ovarian Tumors
![Table III from The diagnostic value of serum HE4 and CA-125 and ROMA index in ovarian cancer | Semantic Scholar Table III from The diagnostic value of serum HE4 and CA-125 and ROMA index in ovarian cancer | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/ad5e941b87910036df87050d122d3db985bbadce/3-TableIII-1.png)
Table III from The diagnostic value of serum HE4 and CA-125 and ROMA index in ovarian cancer | Semantic Scholar
![Evaluation of ovarian cancer remission markers HE4, MMP7 and Mesothelin by comparison to the established marker CA125 - ScienceDirect Evaluation of ovarian cancer remission markers HE4, MMP7 and Mesothelin by comparison to the established marker CA125 - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0090825811009735-fx2.jpg)
Evaluation of ovarian cancer remission markers HE4, MMP7 and Mesothelin by comparison to the established marker CA125 - ScienceDirect
![Simultaneous Detection of Ovarian Cancer-Concerned HE4 and CA125 Markers Based on Cu Single-Atom-Triggered CdS QDs and Eu MOF@Isoluminol ECL | Analytical Chemistry Simultaneous Detection of Ovarian Cancer-Concerned HE4 and CA125 Markers Based on Cu Single-Atom-Triggered CdS QDs and Eu MOF@Isoluminol ECL | Analytical Chemistry](https://pubs.acs.org/cms/10.1021/acs.analchem.3c00273/asset/images/large/ac3c00273_0008.jpeg)
Simultaneous Detection of Ovarian Cancer-Concerned HE4 and CA125 Markers Based on Cu Single-Atom-Triggered CdS QDs and Eu MOF@Isoluminol ECL | Analytical Chemistry
![Diagnostics | Free Full-Text | Evaluation of He4 Use in the Diagnosis of Ovarian Cancer: First and Second Recurrence, and an Analysis of HE4 Concentration during Second- and Third-Line Chemotherapy Diagnostics | Free Full-Text | Evaluation of He4 Use in the Diagnosis of Ovarian Cancer: First and Second Recurrence, and an Analysis of HE4 Concentration during Second- and Third-Line Chemotherapy](https://pub.mdpi-res.com/diagnostics/diagnostics-13-00452/article_deploy/html/images/diagnostics-13-00452-g001.png?1675751411)
Diagnostics | Free Full-Text | Evaluation of He4 Use in the Diagnosis of Ovarian Cancer: First and Second Recurrence, and an Analysis of HE4 Concentration during Second- and Third-Line Chemotherapy
![Reference ranges for HE4 and CA125 in a large Asian population by automated assays and diagnostic performances for ovarian cancer - Park - 2012 - International Journal of Cancer - Wiley Online Library Reference ranges for HE4 and CA125 in a large Asian population by automated assays and diagnostic performances for ovarian cancer - Park - 2012 - International Journal of Cancer - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/1e28ef43-c740-4fed-8a87-890cd2491360/ntbl004.jpg)
Reference ranges for HE4 and CA125 in a large Asian population by automated assays and diagnostic performances for ovarian cancer - Park - 2012 - International Journal of Cancer - Wiley Online Library
![Cureus | The Diagnostic Accuracy of Serum and Urine Human Epididymis Protein 4 (HE4) in Ovarian Cancer in 15,394 Subjects: An Updated Meta-Analysis Cureus | The Diagnostic Accuracy of Serum and Urine Human Epididymis Protein 4 (HE4) in Ovarian Cancer in 15,394 Subjects: An Updated Meta-Analysis](https://assets.cureus.com/uploads/figure/file/450386/lightbox_47ac61c04e1611ed866f3f2f10f68ed1-Figure-1.png)
Cureus | The Diagnostic Accuracy of Serum and Urine Human Epididymis Protein 4 (HE4) in Ovarian Cancer in 15,394 Subjects: An Updated Meta-Analysis
![Is HE4 Superior over CA-125 in the Follow-up of Patients with Epithelial Ovarian Cancer? | Bentham Science Is HE4 Superior over CA-125 in the Follow-up of Patients with Epithelial Ovarian Cancer? | Bentham Science](http://www.eurekaselect.com/images/graphical-abstract/cdt/21/10/006.jpg)
Is HE4 Superior over CA-125 in the Follow-up of Patients with Epithelial Ovarian Cancer? | Bentham Science
![A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses | Clinics A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses | Clinics](https://multimedia.elsevier.es/PublicationsMultimediaV1/file//18075932/0000006700000005/v1_202212011555/S1807593222018178/v1_202212011555/en/main.assets/gr1.jpeg?xkr=ue/ImdikoIMrsJoerZ+w997EogCnBdOOD93cPFbanNfuNpdT3pEXC7tmqfbE1Y0Z1p9+vAlVDCDNpqpxHzzp8Z0ILrOhT7YePrkmPFgJXhRefw4ABU3JKFsav571eCDEBUhjI79Bed2vwyg+06u15e5p0zEc7NR8pKOODemQ8Jl7shbpnR5Z7fS6msjciMc9exfReX6xEt3CpsUcLrQq2+COvxzN0YvO0v9diCVzdtXH5DjBo0uguSf7DejoHnqvOJgN9DgkVeQr5ZRPIsThWOr2uAw3C2JxlJ7ad8KbJ5A=)
A comparison of CA125, HE4, risk ovarian malignancy algorithm (ROMA), and risk malignancy index (RMI) for the classification of ovarian masses | Clinics
![Sensors | Free Full-Text | An SPRi Biosensor for Determination of the Ovarian Cancer Marker HE4 in Human Plasma Sensors | Free Full-Text | An SPRi Biosensor for Determination of the Ovarian Cancer Marker HE4 in Human Plasma](https://www.mdpi.com/sensors/sensors-21-03567/article_deploy/html/images/sensors-21-03567-g001.png)
Sensors | Free Full-Text | An SPRi Biosensor for Determination of the Ovarian Cancer Marker HE4 in Human Plasma
![Frontiers | Beyond the Biomarker: Understanding the Diverse Roles of Human Epididymis Protein 4 in the Pathogenesis of Epithelial Ovarian Cancer Frontiers | Beyond the Biomarker: Understanding the Diverse Roles of Human Epididymis Protein 4 in the Pathogenesis of Epithelial Ovarian Cancer](https://www.frontiersin.org/files/Articles/364491/fonc-08-00124-HTML/image_m/fonc-08-00124-g001.jpg)